Some O O O O
people O O O O
who O O O O
have O O O O
experienced O O O O
symptomatic O O O O
COVID-19 O O O O
infections O O O O
have O O O O
reported O O O O
intense O O O O
side O O O O
effects O O O O
after O O O O
one O O O O
vaccine O O O O
dose, O O O O
leading O O O O
researchers O O O O
to O O O O
believe O O O O
two O O O O
doses O O O O
may O O O O
not O O O O
be O O O O
necessary, O O O O
reports O O O O
[The O O O O
New O O O O
York O O O O
Times](https://www.nytimes.com/2021/02/01/health/have-you-had-covid-19-coronavirus.html?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=109154982&_hsenc=p2ANqtz-98mNlbyvaoKXZWCtKW8esOZnvxHePYEw68dYi_WxrrV4DpU6GmApJ_7qxwPivJnjvcD_y7pzUrkewhRinN_zHY7Osdgy_d8TKT8VZ49O5zQNuCiBQ&utm_content=109154982&utm_source=hs_email). O O O O
In O O O O
a O O O O
study O O O O
[published](https://www.medrxiv.org/content/10.1101/2021.01.29.21250653v1) O O O O
Feb. O O O O
1 O O O O
in O O O O
medRxiv, O O O O
researchers O O O O
found O O O O
that O O O O
people O O O O
who O O O O
had O O O O
previously O O O O
been O O O O
infected O O O O
with O O O O
COVID-19 O O O O
reported O O O O
fatigue, O O O O
headache, O O O O
chills, O O O O
fever, O O O O
and O O O O
muscle O O O O
and O O O O
joint O O O O
pain O O O O
after O O O O
the O O O O
first O O O O
vaccine O O O O
dose O O O O
more O O O O
frequently O O O O
than O O O O
those O O O O
who O O O O
had O O O O
never O O O O
had O O O O
COVID-19. O O O O
COVID-19 O O O O
survivors O O O O
also O O O O
had O O O O
significantly O O O O
higher O O O O
antibody O O O O
levels O O O O
after O O O O
both O O O O
the O O O O
first O O O O
and O O O O
second O O O O
doses O O O O
of O O O O
the O O O O
vaccine. O O O O
The O O O O
researchers O O O O
concluded O O O O
that O O O O
people O O O O
who O O O O
have O O O O
had O O O O
COVID-19 O O O O
may O O O O
need O O O O
only O O O O
one O O O O
shot. O O O O
The O O O O
study O O O O
has O O O O
yet O O O O
to O O O O
be O O O O
peer O O O O
reviewed. O O O O
"I O O O O
think O O O O
one O O O O
vaccination O O O O
should O O O O
be O O O O
sufficient," O O O O
said O O O O
Florian O O O O
Krammer, O O O O
PhD, O O O O
a O O O O
virologist O O O O
at O O O O
New O O O O
York O O O O
City-based O O O O
Icahn O O O O
School O O O O
of O O O O
Medicine O O O O
at O O O O
Mount O O O O
Sinai O O O O
and O O O O
an O O O O
author O O O O
of O O O O
the O O O O
study. O O O O
"This O O O O
would O O O O
also O O O O
spare O O O O
individuals O O O O
from O O O O
unnecessary O O O O
pain O O O O
when O O O O
getting O O O O
the O O O O
second O O O O
dose O O O O
and O O O O
it O O O O
would O O O O
free O O O O
up O O O O
additional O O O O
vaccine O O O O
doses." O O O O
Another Reason 3 O O
study Reason 3 O O
also Reason 3 O O
[published](https://www.medrxiv.org/content/10.1101/2021.01.30.21250843v2) Reason 3 O O
Feb. Reason 3 O O
1 Reason 3 O O
in Reason 3 O O
medRxiv Reason 3 O O
supports Reason 3 O O
the Reason 3 O O
single Reason 3 O O
dose Reason 3 O O
idea, Reason 3 O O
with Reason 3 O O
authors Reason 3 O O
concluding Reason 3 O O
that Reason 3 O O
those Reason 3 O O
who Reason 3 O O
have Reason 3 O O
previously Reason 3 O O
tested Reason 3 O O
positive Reason 3 O O
for Reason 3 O O
COVID-19 Reason 3 O O
should Reason 3 O O
be Reason 3 O O
moved Reason 3 O O
down Reason 3 O O
the Reason 3 O O
priority Reason 3 O O
list Reason 3 O O
and Reason 3 O O
get Reason 3 O O
only Reason 3 O O
one Reason 3 O O
vaccine Reason 3 O O
while Reason 3 O O
supplies Reason 3 O O
are Reason 3 O O
limited. Reason 3 O O
The O O O O
study O O O O
did O O O O
not O O O O
explore O O O O
vaccine O O O O
side O O O O
effects O O O O
and O O O O
has O O O O
yet O O O O
to O O O O
be O O O O
peer O O O O
reviewed. O O O O
Changing Reason 2 O O
the Reason 2 O O
number Reason 2 O O
of Reason 2 O O
doses Reason 2 O O
could Reason 2 O O
create Reason 2 O O
"a Reason 2 O O
really Reason 2 O O
tricky Reason 2 O O
precedent," Reason 2 O O
said Reason 2 O O
E. Reason 2 O O
John Reason 2 O O
Wherry, Reason 2 O O
PhD, Reason 2 O O
director Reason 2 O O
of Reason 2 O O
Philadelphia-based Reason 2 O O
University Reason 2 O O
of Reason 2 O O
Pennsylvania's Reason 2 O O
Institute Reason 2 O O
for Reason 2 O O
Immunology. Reason 2 O O
"We Reason 2 O O
don't Reason 2 O O
take Reason 2 O O
FDA Reason 2 O O
approvals Reason 2 O O
of, Reason 2 O O
say, Reason 2 O O
a Reason 2 O O
chemotherapeutic Reason 2 O O
drug Reason 2 O O
and Reason 2 O O
then Reason 2 O O
just Reason 2 O O
throw Reason 2 O O
out Reason 2 O O
the Reason 2 O O
dosage Reason 2 O O
schedule," Reason 2 O O
he Reason 2 O O
told Reason 2 O O
the Reason 2 O O
NYT. Reason 2 O O
The O O O O
CDC O O O O
is O O O O
currently O O O O
investigating O O O O
the O O O O
severe O O O O
vaccine O O O O
reactions O O O O
in O O O O
those O O O O
who O O O O
have O O O O
already O O O O
had O O O O
COVID-19, O O O O
Tom O O O O
Shimabukuro, O O O O
MD, O O O O
deputy O O O O
director O O O O
of O O O O
the O O O O
CDC's O O O O
Immunization O O O O
Safety O O O O
Office, O O O O
said O O O O
Jan. O O O O
27. O O O O
More O O O O
articles O O O O
on O O O O
public O O O O
health: O O O O
[COVID-19 O O O O
test O O O O
positivity O O O O
falls O O O O
for O O O O
2nd O O O O
week O O O O
in O O O O
row: O O O O
